{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:00:43Z","timestamp":1762527643584,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajoc.2019.100560","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T02:11:55Z","timestamp":1569463915000},"page":"100560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use"],"prefix":"10.1016","volume":"16","author":[{"given":"Abdelrahman M.","family":"Elhusseiny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Relhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Smiddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2019.100560_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40265-013-0055-x","article-title":"Drug-induced macular edema","volume":"73","author":"Makri","year":"2013","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ajoc.2019.100560_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00006324-200304000-00004","article-title":"Cystic maculopathy with normal capillary permeability secondary to docetaxel","volume":"80","author":"Teitelbaum","year":"2003","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.ajoc.2019.100560_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08820530701457373","article-title":"Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome","volume":"22","author":"Telander","year":"2007","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2019.100560_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-015-0020-4","article-title":"Bilateral cystoid macular edema following docetaxel chemotherapy in a patient with retinitis pigmentosa: a case report","volume":"15","author":"Enzsoly","year":"2015","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2019.100560_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000455088","article-title":"Docetaxel retinopathy: a case report","volume":"8","author":"Nghiem-Buffet","year":"2017","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2019.100560_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3892\/mco.2017.1296","article-title":"Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: a case report","volume":"7","author":"Bassi","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"7","key":"10.1016\/j.ajoc.2019.100560_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1517\/14656566.6.7.1073","article-title":"The role of taxanes in the treatment of breast cancer","volume":"6","author":"Nabholtz","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ajoc.2019.100560_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","article-title":"The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents","volume":"48","author":"Rowinsky","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajoc.2019.100560_bib9","doi-asserted-by":"crossref","unstructured":"Moloney T, Xu W, Rallah-Baker K, Oliveira N, Woodward N, Farrah J. Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report. BMC Ophthalmol. 201 ;Feb 24;14(1):18.","DOI":"10.1186\/1471-2415-14-18"},{"key":"10.1016\/j.ajoc.2019.100560_bib10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0161-6420(00)00640-0","article-title":"Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect","volume":"108","author":"Esmaeli","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2019.100560_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.ICL.0000062464.79558.5A","article-title":"Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere)","volume":"29","author":"Skolnick","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajoc.2019.100560_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-06","article-title":"Early detection of tamoxifen-induced maculopathy in patients with low cumulative doses of tamoxifen","author":"Chung","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajoc.2019.100560_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archopht.125.5.709","article-title":"Paclitaxel maculopathy","volume":"125","author":"Joshi","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.100560_bib14","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0161-6420(88)32955-6","article-title":"Niacin maculopathy","volume":"95","author":"Jampol","year":"1988","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2019.100560_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10792-012-9558-9","article-title":"The mystery of angiographically silent macular oedema due to taxanes","volume":"32","author":"Kuznetcova","year":"2012","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2019.100560_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/taap.1994.1210","article-title":"Seminiferous tubule fluid secretion is a sertoli cell microtubule-dependent process inhibited by 2,5-hexanedione exposure","volume":"128","author":"Richburg","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.ajoc.2019.100560_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000477897","article-title":"Cystoid macular edema during treatment with paclitaxel and bevacizumab in a patient with metastatic breast cancer: a case report and literature review","volume":"10","author":"Yokoe","year":"2017","journal-title":"Case Rep Oncol"},{"issue":"11","key":"10.1016\/j.ajoc.2019.100560_bib18","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archopht.126.11.1605","article-title":"Cystoid macular edema secondary to albumin-bound paclitaxel therapy","volume":"126","author":"Smith","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.100560_bib19","first-page":"322","article-title":"Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. review","volume":"7","author":"Geamanu Panca","year":"2014","journal-title":"J Med Life"},{"issue":"1A","key":"10.1016\/j.ajoc.2019.100560_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","article-title":"Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ajoc.2019.100560_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-017-0517-0","article-title":"The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report","volume":"17","author":"Hong","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2019.100560_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ophtha.2015.09.011","article-title":"Nonleaking cystoid macular edema as a presentation of hydroxychloroquine retinal toxicity","volume":"123","author":"Parikh","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajoc.2019.100560_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbt.21696","article-title":"Chloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeability","volume":"29","author":"Korthagen","year":"2015","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.ajoc.2019.100560_bib24","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.jcjo.2017.10.022","article-title":"Effect of topical dorzolamide therapy on cystoid macular edema in hydroxychloroquine retinopathy","volume":"53","author":"Kim","year":"2018","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2019.100560_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-018-0985-x","article-title":"Intravitreal dexamethasone implant therapy for the treatment of cystoid macular oedema due to hydroxychloroquine retinopathy: a case report and literature review","volume":"18","author":"Ahn","year":"2018","journal-title":"BMC Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993619301033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993619301033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:08Z","timestamp":1762527428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993619301033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"alternative-id":["S2451993619301033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2019.100560","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2019.100560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100560"}}